Professor Michael P. Lisanti, Director of the Breakthrough Breast Cancer Unit, led the research. He was inspired to look at the effects of antibiotics on the mitochondria of cancer stem cells by a conversation with his daughter ...
For the past two decades, the National Cancer Institute has documented a persistent racial disparity in colon cancer survival rates in the United States.
Do terminally ill patients in New Mexico already have the right to end their lives?
A new study published in ecancermedicalscience examines the intersection of medical journalism and cancer research.
A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer.